Vertex Pharmaceuticals (NASDAQ: VRTX) is a great example of biotech success. It recently won approval for a non-opioid pain ...

As biotech investors know, companies in the industry can sometimes earn significant returns in relatively short periods, like ...

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $34.26, moving -1.81% from the previous trading session.

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has received an average recommendation of “Hold” from the twenty-one research firms that are currently covering the stock, MarketBeat.com reports ...

I t's shaping up to be another rocky week of trading, and the volatility will probably keep Cathie Wood busy. The co-founder, ...

Of the pure-play gene editing specialists on the market, CRISPR Therapeutics (NASDAQ: CRSP) is one of the more prominent. CRISPR Therapeutics (NasdaqGM:CRSP) experienced an 12% price decline over ...

Recursion Pharmaceuticals (NASDAQ: RXRX), and CRISPR Therapeutics (NASDAQ: CRSP), plunged in March, with the stocks down 35.3 ...

Below is Validea's guru fundamental report for CRISPR THERAPEUTICS AG (CRSP). Of the 22 guru strategies we follow, CRSP rates highest using our Value Investor model based on the published strategy ...

In trading on Tuesday, shares of CRISPR Therapeutics AG (Symbol: CRSP) entered into oversold territory, hitting an RSI reading of 29.6, after changing hands as low as $33.05 per share. By ...

Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) ...

After yesterday's massive rally that saw the stock market add $5.5 trillion in value after President Trump paused for 90 days ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $32.65 ... and the technology-dominated Nasdaq saw a decrease of 5.82%. Prior to today's trading, shares of the company ...